
"Another U.S.-based one that's pretty interesting is Vext Science, ticker V-E-X-T-F. It operates in branded products and cultivation, has a market cap of around $60 million, gained 24% over the last month, with EBITDA margins 76% above the sector and forward EBITDA growth 677% above sector, alongside trailing discounts of about 70% in price-to-book and price-to-cash flow."
Vext Science, ticker V-E-X-T-F, is a high-potential, small-cap cannabis play. Its impressive recent momentum, substantial profitability advantages, and significant valuation discounts make it an actionable strong buy recommendation for investors looking to capitalize on the growth potential in the U.S. cannabis industry.
Quant buys in cannabis
September 11, 2025
Stock Idea